30
Jul 2026
QUANTUM trial tests immune-targeting approach for primary plasma cell leukemia
The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (PCL).